Mark Ghobrial, M.D. Comes to Houston to Head Up Methodist Liver Transplant Program

[Guest guest]

Mark Ghobrial, M.D. Comes to Houston to Head Up Methodist Liver Transplant

Program

R.

Mark Ghobrial, MD, PhD, FRCS (Ed)

New

Director of Liver Transplant Program

The Methodist Hospital, Houston, TX

Dr.

Ghobrial is currently Professor of

Surgery in the Division of Liver and Pancreas Transplantation, Department of

Surgery, Geffen School of Medicine at University of California, Los

Angeles (UCLA). He is the Director of the Living Donor Liver

Transplant Program and the Pancreas Transplantation Program at UCLA.

Dr. Ghobrial has been recruited to the Methodist

Hospital, Houston, Texas as Director of the Comprehensive

Liver Center; Director of Liver Transplantation ; Director of the Immunobiology Research Center and Professor of Surgery, Weill Cornell University School of Medicine, he will begin

his position, March 1, 2008

After earning

his MD degree from Cairo University Medical School in Egypt, he

completed his internship at the Massachusetts

General Hospital in Boston and his

surgical residency at the University of Texas/M. D. Cancer Center in Houston. His clinical fellowship in

multi-organ transplantation was conducted at the Dumont-UCLA Liver Transplant Center. During his surgical training, Dr. Ghobrial completed two postdoctoral basic science research

fellowships in immunology at Harvard University and the

University of Texas Medical School at Houston. He went on to receive his PhD in

immunology from the Graduate School of Biomedical Sciences at the University of Texas.

As a

researcher, Dr. Ghobrial maintains an active

laboratory for basic science studies which focus on transplant immunomodulation and the inhibition of chronic rejection by

indirect presentation of class I major histocompatibility

(MHC) molecules and co-stimulatory pathways in allograft recipients. His clinical research interests include partial liver

grafting, adult-to-adult living donor liver transplantation, immunosuppression and transplantation for hepatitis C. He is the principal or co-investigator of

NIH-sponsored basic and clinical research studies, as well as multiple clinical

trials associated with liver transplantation. Dr. Ghobrial is the author or co-author on well over 100

journal articles and book chapters. He lectures

extensively on a variety of topics related to liver transplantation in both

national and international forums, and has received multiple honors and awards. Currently, he is an active member of multiple

transplantation and surgical societies, additionally, the American Surgical

Association and is a fellow of the Royal College of Surgeon of Edingburgh.

[Guest guest]

This article is freely available at http://www.yourhealthfirst.com/en/art/?331

Source: ph S. Galati, M.D.

Arne